| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |